首页> 外国专利> 'all-human antibody, all-human antibody fab fragment, human single-stranded antibody, all-human single-stranded antibody, cancer broad spectrum treatment method, and method of treating inflammatory disorders'

'all-human antibody, all-human antibody fab fragment, human single-stranded antibody, all-human single-stranded antibody, cancer broad spectrum treatment method, and method of treating inflammatory disorders'

机译:“全人抗体,全人抗体fab片段,人单链抗体,全人单链抗体,癌症广谱治疗方法和炎性疾病的治疗方法”

摘要

Relative compositions and methods or derivatives of anti-cx3 antibodies are described. more specifically, fully human cxcr3 binding antibodies, cxcr3 binding fragments and derivatives thereof and cxcr3 binding polypeptides comprising such fragments are described. In addition, nucleic acids encoding such antibodies, antibody fragments, derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments, derivatives and polypeptides and methods of using these antibodies, antibody fragments, derivatives are described. and polypeptides, including methods of treating or diagnosing patients with cxcr3-related conditions or disorders, including various inflammatory disorders and various cancers.
机译:描述了抗cx3抗体的相对组合物和方法或衍生物。更具体地,描述了完全人cxcr3结合抗体,cxcr3结合片段及其衍生物以及包含此类片段的cxcr3结合多肽。另外,描述了编码此类抗体,抗体片段,衍生物和多肽的核酸,包含此类多核苷酸的细胞,制备此类抗体,抗体片段,衍生物和多肽的方法以及使用这些抗体,抗体片段,衍生物的方法。多肽和多肽,包括治疗或诊断患有cxcr3相关疾病或病症的方法,包括各种炎症性疾病和各种癌症。

著录项

  • 公开/公告号BR112017003487A2

    专利类型

  • 公开/公告日2017-11-28

    原文格式PDF

  • 申请/专利权人 SORRENTO THERAPEUTICS INC.;

    申请/专利号BR20171103487

  • 申请日2015-08-07

  • 分类号A61K39/395;A61P35;A61P37/06;G01N33/566;

  • 国家 BR

  • 入库时间 2022-08-21 12:53:51

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号